Velthorst, Eva
Froudist-Walsh, Sean
Stahl, Eli
Ruderfer, Douglas
Ivanov, Ilyan
Buxbaum, Joseph
Børglum, Anders D.
Grove, Jakob
Mattheisen, Manuel
Werge, Thomas
Mortensen, Preben Bo
Pedersen, Marianne Giørtz
Pedersen, Carsten Bøcker
Mors, Ole
Nordentoft, Merete
Hougaard, David M.
Bybjerg-Grauholm, Jonas
Bækvad-Hansen, Marie
Hansen, Christine Søholm
Daly, Mark J.
Neale, Benjamin M.
Robinson, Elise B
Cerrato, Felecia
Dumont, Ashley
Goldstein, Jacqueline
Stevens, Christine
Walters, Raymond
Churchhouse, Claire
Ripke, Stephan
Martin, Joanna
Banaschewski, Tobias
Bokde, Arun L. W.
Dipl-Psych, Uli Bromberg
Büchel, Christian
Quinlan, Erin Burke
Desrivières, Sylvane http://orcid.org/0000-0002-9120-7060
Flor, Herta
Frouin, Vincent http://orcid.org/0000-0001-9360-6623
Garavan, Hugh
Gowland, Penny
Heinz, Andreas
Ittermann, Bernd
Martinot, Marie-Laure Paillère http://orcid.org/0000-0002-0452-2450
Artiges, Eric
Nees, Frauke
Orfanos, Dimitri Papadopoulos http://orcid.org/0000-0002-1242-8990
Paus, Tomáš
Poustka, Luise
Hohmann, Sarah
Fröhner, Juliane H.
Smolka, Michael N. http://orcid.org/0000-0001-5398-5569
Walter, Henrik http://orcid.org/0000-0002-9403-6121
Whelan, Robert
Schumann, Gunter
Reichenberg, Abraham
,
Article History
Received: 11 July 2018
Accepted: 31 July 2018
First Online: 26 September 2018
Conflict of interest
: T.B. has served as an advisor or consultant to Bristol-Myers Squibb, Desitin Arzneimittel, Eli Lilly, Medice, Novartis, Pfizer, Shire, UCB, and Vifor Pharma; he has received conference attendance support, conference support, or speaking fees from Eli Lilly, Janssen McNeil, Medice, Novartis, Shire, and UCB; and he is involved in clinical trials conducted by Eli Lilly, Novartis, and Shire; the present work is unrelated to these relationships. H.W. received a speaker honorarium from Servier (2014). The remaining authors declare that they have no conflict of interest.